NPY and receptors in immune and inflammatory diseases

Current Topics in Medicinal Chemistry

Volumn 7, Issue 17, 2007, Pages 1743-1752

  Wheway, Julie ^a   Herzog, Herbert ^a,b   Mackay, Fabienne ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Asthma; Autoimmunity; Immunity; Inflammation; Neuropeptide Y; Y receptors

Indexed keywords

B LYMPHOCYTE RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROTRANSMITTER; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; AUTOIMMUNITY; CELL ADHESION; CELLULAR DISTRIBUTION; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DERMATOMYOSITIS; DRUG RECEPTOR BINDING; ENTERITIS; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUROMODULATION; NONHUMAN; POLYMYOSITIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SITE DIRECTED MUTAGENESIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VASOCONSTRICTION;

ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y;

EID: 36249008061     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607782341046     Document Type: Review

References (105)

1. Karre, K.; Ljunggren, H.G.; Piontek, G.; Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature, 1986, 319, 675-8.
2. Bendelac, A.; Bonneville, M.; Kearney, J.F. Autoreactivity by design: innate B and T lymphocytes, Nat Rev. Immunol., 2001, 1, 177-86.
3. Starr, T.K.; Jameson, S.C.; Hogquist, K.A. Positive and negative selection of T cells. Annu. Rev. Immunol., 2003, 21, 139-76.
4. Abbas, A.K.; Murphy, K.M.; Sher, A. Functional diversity of helper T lymphocytes. Nature, 1999, 383, 787-93.
5. Wong, P.; Pamer, E.G. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol., 2003, 21, 29-70.
6. Jacobson, D.L.; Gange, S.J.; Rose, N.R.; Graham, N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol., 1997, 84, 223-43.
7. Sinha, A.A.; Lopez, M.T.; McDevitt, H.O. Autoimmune diseases: the failure of self tolerance. Science, 1990, 248, 1380-8.
8. Mackay,, I.R. Science, medicine, and the future: Tolerance and autoimmunity. BMJ, 2000, 321, 93-6.
9. Cohn, L.; Elias, J.A.; Chupp, G.L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol., 2004, 22, 789-815.
10. Robinson, D.S.; Hamid, Q.; Ying, S.; Tsicopoulos, A.; Barkans, J.; Bentley, A.M.; Corrigan, C.; Durham, S.R.; Kay A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 1992, 326, 298-304.
11. Robinson, D.S. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? J. Allergy Clin. Immunol., 2004, 114, 58-65.
12. Hans, W.; Scholmerich, J.; Gross, V.; Falk, W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur. J. Gastroenterol. Hepatol., 2000, 12, 267-73.
13. Liblau, R.S.; Singer, S.M.; McDevitt, H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today, 1995, 16, 34-8.
14. Zamvil, S.S.; Steinman, L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol., 1990, 8, 579-621.
15. Murphy, G.A.; Langrish, C.L.; Chen, Y.; Blumenschein, W.; McClanahan, T.; Kastelein, R.A.; Sedgwick, J.D.; Cua, D.J. Divergent pro- an d antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med., 2003, 198, 1951-7.
16. Langrish, C.L.; Chen, Y.; Blumenschein, W.M.; Mattson, J.; Basham, B.; Sedgwick, J.D.; McClanahan, T.; Kastelein, R.A.; Cua, D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 2005. 201, 233-40.
17. Webster, J.L; Tonelli, L.; Sternberg, E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol., 2002, 20, 125-63.
18. Straub, R.H.; Schaller, T.;. Miller, L.E. von Horsten, S.; Jessop, D.S.; Falk, W.; Scholmerich, J. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J. Neurochem., 2000, 75, 2464-71.
19. Felten, D.L.; Ackerman, K.D.; Wiegand, S.J. and. Felten, S.Y. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J. Neurosci. Res., 1987, 18, 28-36, 118-21.
20. Hoffman-Goetz, L.; Pedersen, B.K. Exercise and the immune system: a model of the stress response? Immunol. Today, 1994, 15, 382-7.
21. Woiciechowsky, C.; Asadullah, K.; Nestler, D.; Eberhardt, B.; Platzer, C.; Schoning, B.; Glockner, F.;. Lanksch, W.R.; Volk, H.D.; Docke, W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med., 1998, 4, 808-13.
22. Utoh, J.; Yamamoto, T.; Utsunomiya, T.; Kambara, T.; Goto, H.; Miyauchi, Y. Effect of surgery on neutrophil functions, superoxide and leukotriene production. Br. J. Surg., 1988, 75, 682-5.
23. Pozo, D.; Delgado, M. The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? FASEB J., 2004, 18, 1325-14.
24. Carr, D.J. Neuroendocrine peptide receptors on cells of the immune system. Chem. Immunol., 1992, 52, 84-105.
25. De la Fuente, M.; Medina, S.; Del Rio, M.; Ferrandez, M.D.; Hernanz, A. Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci., 2000, 67, 2125-35.
26. Bracci-Laudiero, L.; Aloe, L.; Stenfors, C.; Tirassa, P.; Theodorsson, E.; Lundberg, T. Nerve growth factor stimulates production of neuropeptide Y in human lymphocytes. Neuroreport, 1996, 7, 485-8.
27. Glaser, R.; Kiecolt-Glaser, J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol., 2005. 5, 243-51.
28. Lambrecht, B.N. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res., 2001, 2, 133-8.
29. Kruszewska, B.; Felten, S.Y.; Moynihan, J.A. Alterations in cytokihe and antibody production following chemical sympathectomy in two strains of mice. J. Immunol., 1995, 155, 4613-20.
30. Reinke, E.; Fabry, Z. Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides. Immunol. Lett., 2006, 104, 102-9.
31. de Wied, D. Pituitary peptides and behaviour: influence on motivational, learning and memory processes. Excerpta Med. Int. Congr. Ser., 1974, 359, 653-658.
32. Levite, M.; Cahalon, L.; Hershkoviz, R.; Steinman, L.; Lider, O. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J. Immunol., 1999, 160, 993-1000.
33. Schwarz, H.; Villiger, P.M.; von Kempis, J.; Lotz, M. Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol., 1994, 51, 53-61.
34. Medina, S.; Del Rio, M.; Hernanz, A.; De la Fuente. The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication. Regul. Pept., 2000, 95, 35-45.
35. Delgado, M.; Gonzalez-Rey, E.; Ganea, D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J. Immunol., 2005, 175, 7311-24.
36. Gonzalez-Rey, E.; Chomy, A.; Delgado, M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol., 2007, 7, 52-63.
37. Berglund, M.M.; Hipskind, P.A.; Gehlert, D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med., (Maywood), 2003, 228, 217-44.
38. Bedoui, S.; Kawamura, N.; Straub, R.H; Pabst, R.; Yamamura, T.; von Horsten, S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J. Neuroimmunol., 2003, 134, 1-11.
39. Bedoui, S.; Miyake, S.; Straub, R.H.; von Horsten, S.; Yamamura, T. More sympathy for autoimmunity with neuropeptide Y? Trends Immunol., 2004, 25, 508-12.
40. Prod'homme, T.; Weber, M.S.; Steinman, L.; Zamvil, S.S. A neuropeptide in immune-mediated inflammation, Y? Trends Immunol., 2006.
41. Levite, M.; Chowers, Y. Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner. Ann. Oncol., 2001, 12, S19-25.
42. Kawamura, N.; Tamura, H.; Obana, S.; Wenner, M.; Ishikawa, T.; Nakata, A.; Yamamoto, H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation, 1998, 5, 9-15.
43. Jessop, D.; Biswas, S.; D'Souza, L.; Chowdrey, H.; Lightman, S. Neuropeptide Y immunoreactivity in the spleen and thymus of normal rats and following adjuvant-induced arthritis. Neuropeptides, 1992, 23, 203-7.
44. Silva, A.B.; Aw, D.; Palmer, D.B. Evolutionary conservation of neuropeptide expression in the thymus of different species. Immunology, 2006, 118, 131-40.
45. Weihe, E.; Nohr, D.; Michel, S.; Muller, S.; Zentel, H.J.; Fink, T.; Krekel, J. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci., 1991, 59, 1-23.
46. Lundberg, J.M.; Hemsen, A.; Rudehill, A.; Harfstrand, A.; Larsson, O.; Sollevi, A.; Saria, A.; Hokfelt, T.; Fuxe, K. and Fredholm, B.B. Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals. Neuroscience, 1988, 24, 659-72.
47. Romano, T.A.; Felten, S.Y.; Felten, D.L.; Olschowka, J.A. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav. Immun., 1991, 5, 116-31.
48. Felten, S.Y.; Olschowka, J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res., 1987, 18, 37-48.
49. Fink, T.; Weihe, E. Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation? Neurosci. Lett., 1988, 90, 39-44.
50. Felten, D.L.; Felten, S.Y. Immune interactions with specific neural structures. Brain Behav. Immun., 1987, 1, 279-83.
51. Elitsur, Y.; Luk, G.D.; Colberg, M.; Gesell, M.S.; Dosescu, J.; Moshier, J.A. Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes. Neuropeptides, 1994, 26, 289-95.
52. Inoue, N.; Magari, S.; Sakanaka, M. Distribution of peptidergic nerve fibers in rat bronchus-associated lymphoid tissue: light microscopic observations. Lymphology, 1990. 23, 155-60.
53. Ericsson, A.; Schalling, M.; McIntyre, K.R.; Lundberg, J.M.; Larhammar, D.; Seroogy, K.; Hokfelt, T.; Persson, H. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. USA, 1987, 84, 5585-9.
54. Matsuda, H.; Brurnovsky, P.R.; Kopp, J.; Pedrazzini, T.; Hokfelt, T. Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues. J. Comp. Neurol., 2002, 449, 390-404.
55. Petitto, J.M.; Huang, Z.; McCarthy, D.B. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J. Neuroimmunol., 1994, 54, 81-6.
56. Bedoui, S.; Lechner, S.; Gebhardt, T.; Nave, H.; Beck-Sickinger, A.G.; Straub, R.H.; Pabst; R.; von Horsten, S. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor-activation in vivo: sympathetic co-transmission during leukocyte mobilization. J. Neuroimmunol., 2002, 132, 25-33.
57. Gehlert, D.R.; Gackenheimer, S.L. Unexpected high density of neuropeptide Y Y1 receptors in the guinea pig spleen. Peptides, 1996, 17, 1345-8.
58. Bedoui, S.; Miyake, S.; Lin, Y.; Miyamoto, K.; Oki, S.; Kawamura, N.; Beck-Sickinger, A.; von Horsten, S.; Yamamura, T. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J. Immunol., 2003, 171, 3451-8.
59. De la Fuente, M.; Bernaez, I.; Del Rio M.; Hernanz, A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology, 1993, 80, 259-65.
60. Wheway, J.; Mackay, C.R.; Newton, R. A.; Sainsbury, A.; Boey, D.; Herzog, H.; Mackay, F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J. Exp. Med., 2005, 202, 1527-38.
61. Dimitrijevic, M.; Stanojevic, S.; Vujic, V.; Beck-Sickinger, A.; von Horsten, S. Neuropeptide Y. and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul. Pept., 2005, 124, 163-72.
62. Sung, C.P.; Arleth, A.J.; Feuerstein, G.Z. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ. Res., 1991, 68, 314-8.
63. De la Fuente, M.; Del Rio, M.; Medina, S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J. Neuroimmunol., 2001, 116, 156-67.
64. Nave, H.; Bedoui, S.; Moenter, F.; Steffens, J.; Felies, M.; Gebhardt, T.; Straub, R.H.; Pabst, R.; Dimitrijevic, M.; Stanojevic, S. and. von Horsten, S. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol., 2004, 155, 1-12.
65. Bedoui, S.; von Horsten, S.; Gebhardt, T. A role for neuropeptide Y (NPY) in phagocytosis: Implications for innate and adaptive immunity. Peptides, 2007.
66. Hernanz, A.; Tato, E.; De la Fuente, M.; de Miguel, E.; Arnalich, F. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells ftom healthy young and old subjects. J. Neuroimmunol., 1996, 71, 25-30.
67. Hernanz, A.; Medina, S.; de Miguel, E.; Martin-Mola, E. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regul. Pept., 2003, 115, 19-24.
68. Nair, M.P.; Schwartz, S.A.; Wu, K.; Kronfol, Z. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav. Immun., 1993, 7, 70-8.
69. Saurer, T.B.; Ijames, S.G.; Lysle, D.T. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J. Neuroimmunol., 2006, 177, 18-26.
70. De la Fuente, M.; Del Rio, M.; Victor, V.M.; Medina, S. Neuropeptide Y effects on murine natural killer activity: changes with ageing and cAMP involvement. Regul. Pept., 2001, 101, 73-9.
71. Medina, S.; Del Rio, M.; Manuel Victor, V.; Hernanz, A.; De la Fuente, M. Changes with ageing in the modulation of murine lymphocyte chemotaxis by CCK-8S, GRP and NPY. Mech. Ageing Dev., 1998, 102, 249-61.
72. Irwin, M.; Brown, M.; Patterson, T.; Hauger, R.; Mascovich, A.; Grant, I. Neuropeptide Y and natural-killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J., 1991, 5, 3100-7.
73. Arzubiaga, C.; Morrow, J.; Roberts, L.J.2nd.; Biaggioni I. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J. Allergy Clin. Immunol., 1991, 87, 88-93.
74. Soder, O.; Hellstrom, P.M. Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int. Arch. Allergy Appl. Immunol., 1987, 84, 205-11.
75. Medina, S.; Del Rio, M.; Hernanz, A.; De la Fuente, M. Age-related changes in the neuropeptide Y effects on murine lymphoproliferation and interleukin-2 production. Peptides, 2000, 21, 1403-9.
76. Medina, S.; Rio, M.D.; Cuadra, B.D.; Guayerbas, N.; Fuente, M.D. Age-related changes in the modulatory action of gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide in the proliferation of murine lymphocytes. Neuropeptides, 1999, 33, 173-9.
77. Levite, M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad Sci. USA, 1998, 95, 12544-9.
78. Levite, M.; Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann. NY Acad. Sci. USA, 2000, 917, 307-21.
79. Selbie, L.A.; Darby, K.; Schmitz-Peiffer, C.; Browne, C.L.; Herzog, H.; Shine, J.; Biden, T.J. Synergistic interaction of Y1-neuropeptide Y and alpha 1b-adrenergic receptors in the regulation of phospholipase C, protein kinase C, and arachidonic acid production. J. Biol. Chem., 1995, 270, 11789-96.
80. Friedman, E.M.; Irwin, M.R.; Nonogaki, K. Neuropeptide Y inhibits in vivo specific antibody production in rats. Brain Behav. Immun., 1995, 9, 182-9.
81. Snapper, C.M.; Paul, W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science, 1987, 236, 944-7.
82. Straub, R.H.; Mayer, M.; Kreutz, M.; Leeb, S.; Scholmerich, J. and. Falk, W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J. Leukoc. Biol., 2000, 67, 553-8.
83. Straub, R.H.; Westermann, J.; Scholmerich, J.; Falk, W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today, 1998. 19, 409-13.
84. Bedoui, S.; Kuhlmann, S.; Nave, H.; Drube, J.;. Pabst, R and von Horsten, S. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J. Neuroimmunol., 2001, 117, 125-32.
85. von Horsten, S.; Nave, H.; Ballof, J.; Helfritz, F.; Meyer, D.; Schmidt; R.E. Stalp, M.; Exton, N.G.;. Exton, M.S.; Straub, R.H.; Radulovic, J.; Pabst, R. Centrally applied NPY mimics immuno-activation induced by non-analgesic. doses of met-enkephalin. Neuroreport, 1998, 9, 3881-5.
86. von Horsten, S.; Exton, N.G.; Exton, M.S.; Helfritz, F.; Nave, H.; Ballof, J.; Stalp, M.; Pabst, R. Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen. Brain Res., 1998, 806, 282-6.
87. Balasubramaniam, A. Clinical potentials of neuropeptide Y family of hormones. Am. J. Surg., 2002, 183, 430-4.
88. Bettelli, E.; Carrier, Y.; Gao, W.; Korn, T.; Strom, T.B.; Oukka, M.; Weiner, H.L.; Kuchroo, V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006, 441, 235-8.
89. Holmlund, A.; Ekblom, A.; Hansson, P.; Lind, J.; Lundeberg, T.; Theodorsson, E. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings. Int. J. Oral. Maxillofac. Surg., 1991. 20, 228-31.
90. Mapp, P.I.; Kidd, B.L.; Gibson, S.J.; Terry, J.M.; Revell, P.A.; Ibrahim, N.B.; Blake, D.R.; Polak, J.M. Substance P-, calcitonin-gene-retated peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience, 1990, 37, 143-53.
91. Batbayar, B.; Zelles, T.; Ver, A.; Feher, E. Plasticity of the different neuropeptide-containing nerve fibres in the tongue of the diabetic rat. J. Peripher. Nerv. Syst., 2004, 9, 215-23.
92. Maeda, K.; Yasuda, M.; Kaneda, H.; Maeda, S.; Yamadori, A. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Neuropeptides, 1994, 27, 323-32.
93. Gallai, V.; Sarchielli, P. Firenze C.; Trequattrini, A.; Paciaroni, M.; Usai, F.; Franceschini, M.; Palumbo, R. Neuropeptide Y plasma levels and serum dopamine-beta-hydroxylase activity in MS patients with and without abnormal cardiovascular reflexes. Acta Neurol. Belg., 1994, 94, 44-52.
94. Coppin, H.; Ribouchon, M.T.; Fontaine, B. Edan, G.; Clanet, M. and Roth, M.P. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat. Genes Immun, 2004. 5, 72-5.
95. Bracci-Laudiero, L.; Aloe, L.; Lundeberg., T.; Theodorsson, E.; Stenfors, C. Altered levels of neuropeptides characterize the brain of lupus prone mice. Neurosci. Lett., 1999, 275, 57-60.
96. Hay, E.M.; Alack, D.; Huddy, A.; Creed, F.; Tomenson, B.; Bernstein, R-M.; Holt, P.J. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum, 1992, 35, 411-6.
97. Liu, J.; Li, J.; Zhai, N.; Geng, L.; Song, F. Detection of the levels of neuropeptides, ACTH and cortisol in the blood of patients with polymyositis/dermatomyositis and their significance. J. Dermatol., 2004, 31, 392-7.
98. Hassani, H.; Lucas G.; Rozell, B.; Ernfors, P. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 288, G550-6.
99. Chanez, P.; Springall, D.; Vignola, A.M.; Moradoghi-Hattvani, A.; Polak, J.M.; Godard, P.; Bousquet J. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am. J. Respir. Crit. Care Med., 1998, 158, 985-90.
100. Howarth, P.H.; Springall, D.R.; Redington, A.E.; Djukanovic, R.; Holgate, S.T.; Polak, J.M. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am. J. Respir. Cell Mol. Biol., 1995, 13, 288-96.
101. Cardell, L.O.; Uddman, R.; Edvinsson, L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur. Respir. J., 1994, 7, 2169-73.
102. Dahlof, C.; Dahlof, P.; Lundberg, J.M.; Strombom, U. Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma. Pulm. Pharmacol., 1988, 1, 3-6.
103. Barnes, P.I. Th2 cytokines and asthma: an introduction. Respir. Res., 2001, 2, 64-5.
104. Uddman, R.; Cantera, L.; Cardell, L.O.; Edvinnsson L. Expression of NPY Y1 and CGRP1 receptors in human pasal mucosa: implications in allergic rhinitis. Ann. Otol. Rhidol. Laryngol., 1999, 108, 969-73.
105. Zukowska-Grojec, Z.; Dayao, E.K.; Karwatowska-Prokopczuk, E.; Hauser, G.J.; Doods, H.N. tress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am. J. Physiol., 1996. 270, H796-800.